Monday, August 3, 2026
wellness India Expo

Trending Stories

CDSCO approves Takeda’s Qdenga as India’s first dengue vaccine

21
The Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for Takeda’s tetravalent dengue vaccine Qdenga, making it the first dengue vaccine approved in India.

MTaI seeks trade, regulatory and procurement alignment to improve FTA gains...

4
The Medical Technology Association of India (MTaI) has called for closer coordination between India’s Free Trade Agreements and domestic policies covering medical-device regulation, public procurement, investment and workforce mobility.

HAI Conclave 2026 spotlights responsible AI adoption in healthcare

43
Global Healthcare Academy inaugurated HAI Conclave 2026, a two-day conference dedicated to Healthcare and Artificial Intelligence (AI), bringing together clinicians, AI scientists, hospital leaders, researchers, policymakers, startups and technology companies to discuss the responsible adoption of AI in healthcare.

Reader’s Choice

Face to Face

“Research must be designed for translation, not just for publications”: Dr...

394
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem

Chat with BioVoice

“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”

228
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans

R&D

Events